Fireside Chat: Market Strategy – What is the Current State of Play for Reimbursement Across Europe?
Time: 3:00 pm
day: Conference Day Two - Track 2 - PM
Details:
- How has IVDR impacted payer behaviours?
- What is the interplay between companion diagnostic providers, the drug in development, and reimbursement?
- How can drug developers begin thinking about reimbursement earlier in the drug diagnostic development process?
